• 1. Transition metal-catalyzed N-arylations of amidines and guanidines
  Tom R. M. Rauws,Bert U. W. Maes Chem. Soc. Rev. 2012 41 2463
• 2. Exploring the structural landscape of 2-aminopyrazines via co-crystallizations
  Christer B. Aaker?y,Prashant D. Chopade,Claudia Ganser,Arbin Rajbanshi,John Desper CrystEngComm 2012 14 5845
• 3. Recent advances in development of imidazo[1,2-a]pyrazines: synthesis, reactivity and their biological applications
  Richa Goel,Vijay Luxami,Kamaldeep Paul Org. Biomol. Chem. 2015 13 3525
• 4. Transition metal-catalyzed functionalization of pyrazines
  Nicolai I. Nikishkin,Jurriaan Huskens,Willem Verboom Org. Biomol. Chem. 2013 11 3583
• 5. Transition metal-catalyzed functionalization of pyrazines
  Nicolai I. Nikishkin,Jurriaan Huskens,Willem Verboom Org. Biomol. Chem. 2013 11 3583

• Solvents and Organic Chemicals Organic Compounds Heterocyclic Compounds

Recent Advances in the Application of 5-Bromopyrazin-2-amine (CAS: 59489-71-3) in Chemical Biology and Pharmaceutical Research

5-Bromopyrazin-2-amine (CAS: 59489-71-3) is a heterocyclic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by a pyrazine ring substituted with a bromine atom and an amine group, serves as a key intermediate in the synthesis of various bioactive molecules. Recent studies have highlighted its potential in drug discovery, particularly in the development of kinase inhibitors, antimicrobial agents, and anticancer therapeutics. This research brief aims to provide an overview of the latest advancements related to 5-bromopyrazin-2-amine, focusing on its synthesis, biological activities, and therapeutic applications.

One of the most notable developments in the use of 5-bromopyrazin-2-amine is its role as a building block for the synthesis of kinase inhibitors. Kinases are critical regulators of cellular signaling pathways, and their dysregulation is often associated with diseases such as cancer and inflammatory disorders. Researchers have recently reported the successful incorporation of 5-bromopyrazin-2-amine into novel kinase inhibitors, demonstrating its ability to enhance binding affinity and selectivity. For instance, a 2023 study published in the Journal of Medicinal Chemistry described the design of a series of pyrazine-based inhibitors targeting the epidermal growth factor receptor (EGFR), where 5-bromopyrazin-2-amine was utilized to optimize the pharmacokinetic properties of the compounds.

In addition to its applications in kinase inhibitor development, 5-bromopyrazin-2-amine has also shown promise in antimicrobial research. A recent study published in Bioorganic & Medicinal Chemistry Letters explored the synthesis of pyrazine derivatives incorporating 5-bromopyrazin-2-amine and evaluated their activity against drug-resistant bacterial strains. The results revealed that certain derivatives exhibited potent antibacterial effects, particularly against methicillin-resistant Staphylococcus aureus (MRSA). These findings underscore the potential of 5-bromopyrazin-2-amine as a scaffold for developing new antimicrobial agents to address the growing threat of antibiotic resistance.

Another area of interest is the anticancer potential of 5-bromopyrazin-2-amine derivatives. Recent preclinical studies have demonstrated that these compounds can induce apoptosis and inhibit tumor growth in various cancer cell lines. For example, a 2022 study in the European Journal of Medicinal Chemistry reported the synthesis of a novel series of 5-bromopyrazin-2-amine derivatives and their evaluation against breast cancer cells. The lead compound in this series exhibited significant cytotoxicity against MCF-7 cells, with a mechanism of action involving the inhibition of tubulin polymerization. These findings highlight the potential of 5-bromopyrazin-2-amine as a starting point for the development of new anticancer drugs.

The synthesis of 5-bromopyrazin-2-amine has also seen advancements in recent years. Traditional methods often involve multi-step reactions with low yields, but newer approaches have focused on improving efficiency and scalability. A 2023 publication in Organic Process Research & Development described a streamlined synthetic route for 5-bromopyrazin-2-amine using a one-pot reaction strategy, which significantly reduced production costs and environmental impact. This development is particularly relevant for industrial-scale applications, where cost-effective and sustainable synthesis methods are highly desirable.

In conclusion, 5-bromopyrazin-2-amine (CAS: 59489-71-3) continues to be a valuable compound in chemical biology and pharmaceutical research. Its versatility as a building block for kinase inhibitors, antimicrobial agents, and anticancer therapeutics underscores its importance in drug discovery. Recent advancements in synthesis methods further enhance its potential for large-scale applications. Future research should focus on exploring additional therapeutic targets and optimizing the pharmacokinetic properties of 5-bromopyrazin-2-amine derivatives to maximize their clinical potential. As the field progresses, this compound is likely to remain a key player in the development of novel bioactive molecules.

• 24241-18-7(3,5-dibromopyrazin-2-amine)
• 66490-61-7(Aminotribromopyrazine)
• 21943-12-4(3-bromopyrazin-2-amine)
• 446286-92-6(5-Bromo-N-methylpyrazin-2-amine)
• 1001050-24-3(2-Bromo-5-hydrazinopyrazine)
• 446286-94-8(5-Bromo-N,N-dimethylpyrazin-2-amine)
• 54237-53-5(6-Bromopyrazin-2-amine)
• 53338-46-8( )
• 957230-70-5(3,6-Dibromopyrazin-2-amine)
• 89123-58-0(5-Bromopyrazine-2,3-diamine)